Value of GST-P Positive Preneoplastic Hepatic Foci in Dose-Response Studies of Hepatocarcinogenesis: Evidence for Practical Thresholds with Both Genotoxic and Nongenotoxic Carcinogens. A Review of Recent Work
Free accessReview articleFirst published online January, 2003
Value of GST-P Positive Preneoplastic Hepatic Foci in Dose-Response Studies of Hepatocarcinogenesis: Evidence for Practical Thresholds with Both Genotoxic and Nongenotoxic Carcinogens. A Review of Recent Work
Recent low-dose carcinogenesis studies, including major group projects are reviewed. The prevailing paradigm is that carcinogens, particularly genotoxic compounds, have no threshold in exerting their potential for cancer induction. However, the nonthreshold hypothesis can be challenged for cancer risk assessment in humans. A recent very large-scale cooperative effort in Japan furthermore showed that the genotoxic hepatocarcinogen, 2-amino-3,8-dimethylimidazo[4,5- f ]quinoxaline, forms DNA adducts and 8-hydroxy-2'-deoxyguanosine at low doses, but does not induce glutathione S-transferase placental form (GST-P) positive foci as preneoplastic lesions in rat liver (≤10 ppm in diet). Moreover, very low doses of a N-nitroso compound, diethylnitrosamine (DEN), were also found not to significantly induce GST-P positive foci in rat liver (≤0.01 ppm in drinking water). Given the direct correlation between induction of the preneoplastic lesions in the short-term and carcinomas in the longer term with different carcinogens, the results imply a practical nonobserved effect level for hepatocarcinogenicity. Similar results were also observed with so-called nongenotoxic carcinogens such as phenobarbital (PB) and p,p'-dichlorodiphenyltrichloroethane (DDT), which do not exert positive effects on lesion development at very low doses. Furthermore, experiments with application of PB and DDT after treatment with DEN indicate that at very low doses (≤2 ppm in diet), they may even inhibit the development of GST-P positive foci. The data reviewed provide evidence that preneoplastic foci in the liver can be employed as end-point lesions in place of tumors and that exposure to very low levels of carcinogens, typical of those found in the human environment, does not necessarily present as a risk factor.
Bailey GS, Loveland M., Pereira C., Pierce D., Hendricks JD, Groopman JD (1994). Quantitative carcinogenesis and dosimetry in rainbow trout for aflatoxin B1 and aflatoxicol, two aflatoxins that form the same DNA adduct. Mutat Res313: 25—38.
2.
Bannasch P. (1986). Preneoplastic lesions as endpoints in carcinogenicity testing. I. Hepatic preneoplasia. Carcinogenesis7: 689—695.
3.
Bartsch H., Montesano R. (1984). Commentary: Relevance of nitrosamines to human cancer. Carcinogenesis5: 1381—1393.
4.
Boulton R., Woodman A., Calnan D., Selden C., Tam F., Hodgson H. (1997). Nonparenchymal cells from regenerating rat liver generate interleukin-1alpha and -1beta: A mechanism of negative regulation of hepatocyte proliferation. Hepatology26: 49—58.
5.
Carlson TJ, Billings RE (1996). Role ofnitric oxide inthe cytokine-mediated regulation of cytochrome P-450. Mol Pharmacol49: 796—801.
6.
Culp SJ, Gaylor DW, Sheldon WG, Goldstein LS, Beland FA (1998). A comparison of the tumors induced by coal tar and benzo[a]pyrene in a 2-year bioassay. Carcinogenesis19: 117—124.
7.
Druckrey H., Preusmann R., Ivankovic S., Schmähl D. (1967). Organotropic effects of 65 different N-nitroso-compounds in BD-rats. Z Krebsforsch69: 103—210.
8.
Enzmann H., Zerban H., Kopp-Schneider A., Loeser E., Bannasch P. (1995). Effects of low dose of N-nitrosomorpholine on the development of early stages of hepatocarcinogenesis. Carcinogenesis16: 1513—1518.
9.
Fukushima S. , Wanibuchi H., Morimura K., Nakae D., Konishi Y., Tsuda H., Uehara N., Imaida K., Shirai T., Tatematsu M., Tsukamoto T., Hirose M., Furukawa F., Otani S., Yano Y., Wakabayashi K., Totsuka Y. (2002). Lack of a dose-response relationship for carcinogenicity in the rat liver with low doses of 2-amino-3, 8-dimethylimidazo[4,5-f]quinoxaline or N-nitrosodiethylamine . Jpn J Cancer Res93: 1076—1082.
10.
Gaylor DW (1979). Summary and conclusions. J Environ Pathol Toxicol3: 179—183.
11.
Geller DA, de Vera ME, Russell DA, Shapiro RA, Nussler AK, Simmons RL (1995). A central role for IL-1 beta in the in vitro and in vivo regulation of hepatic inducible nitric oxide synthase. IL-1 beta induces hepatic nitric oxide synthesis. J Immunol155: 4890—4898.
12.
IARC working group on the evaluation of carcinogenic risk to humans (1993). MeIQx (2-Amino-3,8-dimethylimidazo[4,5-f]quinoxaline) . In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans— Some Naturally Occurring Substances: Food Items and Constituents, Heterocyclic Aromatic Amines and Mycotoxins, vol 56, IARC, Lyon, France, pp 211—228.
13.
Ito A., Taki T., Matsumura T., Onozaki K. (1999). Augmentation of type 1 IL-1 receptor expression and IL-1 signaling by IL-6 and glucocorticoid in murine hepatocytes. J Immunol162: 4260—4265.
14.
Ito N., Tsuda H., Tatematsu M., Inoue T., Tagawa Y. Aoki T., Uwagawa S., Kagawa M., Ogiso T., Masui T., Imaida K., Fukushima S., Asamoto M. (1988). Enhancing effect of various hepatocarcinogens on induction of preneoplastic glutathione S-transferase placental form positive foci in rats an approach for a new medium-term bioassay system. Carcinogenesis9: 387—394.
15.
Kasai H. (1997). Analysis of a form of oxidative DNA damage, 8-hydroxy2'-deoxyguanosine, as a marker of cellular oxidative stress during carcinogenesis. Mutat Res387: 147—163.
16.
Kasai H., Nishimura S., Kurokawa Y., Hayashi Y. (1987). Oral administration of renal carcinogen, potassium bromate, specifically produces 8-hydroxydeoxyguanosine in rat target organ DNA. Carcinogenesis8: 1959—1961.
17.
Kasai H., Okada Y., Nishimura S., Rao MS, Reddy JK (1989). Formation of 8-hydroxydeoxyguanosine in liver DNA of rats following long-term exposure to a peroxisome proliferator. Cancer Res49: 2603—2605.
18.
Kato T., Hasegawa R., Nakae D., Hirose M., Yaono M., Cui L., Kobayashi Y., Konishi N., Ito N., Shirai T. (1996). Dose-dependent induction of 8-hydroxyguanine and preneoplastic foci in rat liver by a food-derived carcinogen, 2-amino-3,8-dimethylimidazo[4,5-f ]quinoxaline, at low dose levels. Jpn J Cancer Res87: 127—133.
19.
Kato T., Ohgaki H., Hasegawa H., Sato S., Takayama S., Sugimura T. (1988). Carcinogenicity in rats of a mutagenic compound, 2-amino-3,8-dimethylimidazo[4,5-f ]quinoxaline. Carcinogenesis9: 71—73.
20.
Kitano M., Ichihara T., Matsuda T., Wanibuchi H., Tamano S., Hagiwara A., ImaokaS., Funae Y., Shirai T., Fukushima S. (1998). Presence ofathresholdfor promoting effects of phenobarbital on diethylnitrosamine-induced hepatic foci in the rat. Carcinogenesis19: 1475—1480.
21.
Kleczkowska HE, Althaus FR (1996). Response of human keratinocytes to extremely low concentrations of N-methyl-N'-nitro-N-nitrosoguanidine . Mutat Res367: 151—159.
22.
Littlefield NA, Farmer JH, Gaylor DW, Sheldon WG (1979). Effects of dose and time in a long-term, low-dose carcinogenic study. J Environ Pathol Toxicol3: 17—34.
23.
Maeda H., Sato K., Akaike T. (1995). Superoxide radical generation from heterocyclic amines. In: Heterocyclic Amines in Cooked Foods: Possible Human Carcinogens, Adamson RH, Gustafsson J-A, Ito N , Nagao M, Sugimura T, Wakabayashi K, Yamazoe Y (eds). Princeton Scientific Publishing Co, Inc, Princeton, NJ, pp 103—112.
24.
Maekawa A., Onodera H., Ogasawara H., Matsushima Y., Mitsumori K., Hayashi Y. (1992). Threshold dose dependence in phenobarbital promotion of rat hepatocarcinogenesis initiated by diethylnitrosamine. Carcinogenesis13: 501—503.
25.
Masuda C., Wanibuchi H., Otori K., Wei M., Yamamoto S., Hiroi T., Imaoka S., Funae Y., Fukushima S. (2002). Presence of no-observed effect level for enhancing effcts of the α-isomer of benzene hexachloride (α-BHC) on diethylnitrosamine-initiated hepatic foci in rats. Cancer Lett163: 179—185.
26.
Murray S., Gooderham NJ, Boobis AR, Davis DS (1989). Detection and measurement of MeIQx in human urine after ingestion of a cooked meat meal. Carcinogenesis10: 763—765.
27.
Nakae D., Kobayashi Y., Akai H., Andoh N., Satoh H., Ohashi K., Tsutsumi M., Konishi Y. (1997). Involvement of 8-hydroxyguanine formation in the initiation of rat liver carcinogenesis by low dose levels ofN-nitrosodiethylamine . Cancer Res57: 1281—1287.
28.
Ogiso T., Tatematsu M., Tamano S., Hasegawa R., Ito N. (1990). Correlation between medium-term liver bioassay system data and results of long-term testing in rats. Carcinogenesis11: 561—566.
29.
International Conference of Harmonization (ICH) (1997). Guidance for industry. S1B Testing for Carcinogenicity of Pharmaceuticals. 3—4.
30.
Olivieri G., Bodycote J., Wolff S. (1984). Adaptive response of human lymphocytes to low concentrations of radioactive thymidine. Science223: 594—597.
31.
Peto R., Gray R., Brantom P., Grasso P. (1991). Effects on 4080 rats of chronic ingestion of N-nitrosodiethylamine or N-nitrosodimethylamine: A detailed dose-response study. Cancer Res51: 6415—6451.
32.
Poirier MC, Santella RM, Weston A. (2000). Carcinogen macromolecular adducts and their measurement . Carcinogenesis21: 353—359.
33.
Preussmann R. (1980). The problem of thresholds in chemical carcinogenesis—Some views on theoretical and practical aspects . J Cancer Res Clin Oncol97: 1—14.
34.
Ross HJ (1996). The antiproliferative effect of trans-retinoic acid is associated with selective induction of interleukin-1 beta, a cytokine that directly inhibits growth of lung cancer cells. Oncol Res8: 171—178.
35.
Sato K., Kitahara A., Satoh K., Ishikawa T., Tatematsu M., Ito N. (1984). The placental form of glutathione S-transferase as a new marker protein for preneoplasia in rat chemical hepatocarcinogenesis . Gann75: 199—202.
36.
Shirai T. (1997). A medium-term liver bioassay as a rapid in vivo test for carcinogenic potential: A histroical review of model development and summary of results from 291 tests. Toxicol Pathol25: 453—460.
37.
SpiegelhalderD, Preussmann R(1983). Occupational nitrosamine exposure. 1. Rubber and Tyre industry. Carcinogenesis4: 1147—1152.
38.
Sugimura T. (1995). History, present and future, of heterocyclic amines, cooked food mutagens. In: Heterocyclic Amines in Cooked Foods: Possible Human Carcinogens, Adamson RH, Gustafsson J-Å, Ito N , Nagao M, Sugimura T, Wakabayashi K, Yamazoe Y (eds). Princeton Scientific Publishing Co, Inc, Princeton, NJ, pp 214—231.
39.
Sugimura T. (2000). Nutrition and dietary carcinogens . Carcinogenesis21: 387—395.
40.
Sugimura T. , Terada M., Yokota J., Hirohashi S., Wakabayashi K. (1992). Multiple genetic alterations in human carcinogensis. Environ Health Perspect98: 5—12.
41.
Sukata T., Uwagawa S., Ozaki K., Ogawa M., Nishikawa T., Iwai S., Kinoshita A., Wanibuchi H., Imaoka S., Funae Y., Okuno Y., Fukushima S. (2002). Detailed low dose study of 1,1-bis(p-chlorophenyl)-2,2,2-trichloroethane carcinogenesis suggests the possibility of a hormetic effect. Int J Cancer99: 112—118.
42.
Tannenbaum SR, Stillwell WG, Ji H., Skipper PL, Yu MC, Ross RK, Henderson BE, Turesky RJ, Gross GA (1995). MeIQx (2-Amino-3,8-dimethylimidazo[4,5-f]quinoxaline): Metabolism in humans and urinary metabolites in human populations. In: Heterocyclic Amines in Cooked Foods: Possible Human Carcinogens , Adamson RH, Gustafsson J-A, Ito N, Nagao M, Sugimura T, Wakabayashi K, Yamazoe Y (eds). Princeton Scientific Publishing Co, Inc, Princeton, NJ, pp 197—206.
43.
Tennekes HA , Edler L., Kunz HW (1982). Dose-response analysis of the enhancement of liver tumour formation in CF-1 mice by dieldrin. Carcinogenesis3: 941—945.
44.
Tomatis L., Huff J., Hertz-Picciotto I., Sandler DP, Bucher J., Boffetta P., Axelson O., Blair A., Taylor J., Stayner L., Barrett JC (1997). Avoided and avoidable risk of cancer. Carcinogenesis18: 97—105.
45.
Totsuka Y., Fukutome K., Takahashi M., Takahashi S., Tada A., Sugimura T., Wakabayashi K. (1996). Presence of N2-(deoxyguanosin-8-yl)-2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (dG-C8-MeIQx) in human tissues. Carcinogenesis17: 1029—1034.
46.
Umemura T., Tokumo K., Sirma H., Gebhardt R., Poirier MC, Williams GM (1993). Dose response effects of 2-acetylaminofluorence on DNA damage, cytotoxicity, cell proliferation and neoplastic conversion in rat liver. Cancer Lett73: 1—10.
47.
Ushiyama H. , Wakabayashi K., Hirose M., Itoh H., Sugimura T., Nagao M. (1991). Presence of carcinogenic heterocyclic amines in urine of healthy volunteers eating normal diet, but not in patients receiving parenteral alimentation . Carcinogenesis12: 1417—1422.
48.
Wang Z., Wang M., Carr BI ( 1998). The inhibitory effect of interleukin on rat hepatocyte DNA synthesis is mediated by nitric oxide. Hepatology28: 430—435.
49.
Williams GM , Gebhardt R., Sirma H., Stenbaeck F. (1993). Non-linearity of neoplastic conversion induced in rat liver by low exposures to diethylnitrosamine. Carcinogenesis14: 2149—2156.
50.
Witz G. (1991). Active oxygen species as factors in multistage carcinogenesis. Proc Soc Exp Biol Med198: 675—682.
51.
Wollff S. (1998). The adaptive response in radiobiology: Evolving insights and implications. Environ Health Perspect106 (Suppl 1): 277—283.
52.
Yamashita K. , Adachi M., Kato S., Nakagama H., Ochiai M., Wakabayashi K., Sato S., Nagao M., Sugimura T. (1990). DNA adducts formed by 2-amino-3,8dimethylimidazo[4,5-f]quinoxaline in rat liver: Dose-response on chronic administration. Jpn J Cancer Res81: 470—476.
